These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 9922099)

  • 1. Genetic mutations resulting in estrogen insufficiency in the male.
    Simpson ER
    Mol Cell Endocrinol; 1998 Oct; 145(1-2):55-9. PubMed ID: 9922099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene.
    Fisher CR; Graves KH; Parlow AF; Simpson ER
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6965-70. PubMed ID: 9618522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of spermatogenesis in mice lacking a functional aromatase (cyp 19) gene.
    Robertson KM; O'Donnell L; Jones ME; Meachem SJ; Boon WC; Fisher CR; Graves KH; McLachlan RI; Simpson ER
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7986-91. PubMed ID: 10393934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of estrogen deficiency in the male: the ArKO mouse model.
    Murata Y; Robertson KM; Jones ME; Simpson ER
    Mol Cell Endocrinol; 2002 Jul; 193(1-2):7-12. PubMed ID: 12160996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes.
    Korach KS; Couse JF; Curtis SW; Washburn TF; Lindzey J; Kimbro KS; Eddy EM; Migliaccio S; Snedeker SM; Lubahn DB; Schomberg DW; Smith EP
    Recent Prog Horm Res; 1996; 51():159-86; discussion 186-8. PubMed ID: 8701078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility.
    Eddy EM; Washburn TF; Bunch DO; Goulding EH; Gladen BC; Lubahn DB; Korach KS
    Endocrinology; 1996 Nov; 137(11):4796-805. PubMed ID: 8895349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Estrogen resistance and aromatase deficiency in humans].
    Carani C; Fabbi M; Zirilli L; Sgarbi I
    J Soc Biol; 2002; 196(3):245-8. PubMed ID: 12462077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the fertility of male aromatase knockout mice.
    Robertson KM; Simpson ER; Lacham-Kaplan O; Jones ME
    J Androl; 2001; 22(5):825-30. PubMed ID: 11545296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of estrogen receptors in the forebrain of aromatase knockout (ArKO) mice.
    Agarwal VR; Sinton CM; Liang C; Fisher C; German DC; Simpson ER
    Mol Cell Endocrinol; 2000 Apr; 162(1-2):9-16. PubMed ID: 10854693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency.
    Takeda K; Toda K; Saibara T; Nakagawa M; Saika K; Onishi T; Sugiura T; Shizuta Y
    J Endocrinol; 2003 Feb; 176(2):237-46. PubMed ID: 12553872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic mutations resulting in loss of aromatase activity in humans and mice.
    Simpson ER
    J Soc Gynecol Investig; 2000; 7(1 Suppl):S18-21. PubMed ID: 10732324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen: consequences and implications of human mutations in synthesis and action.
    Grumbach MM; Auchus RJ
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4677-94. PubMed ID: 10599737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene.
    Herrmann BL; Saller B; Janssen OE; Gocke P; Bockisch A; Sperling H; Mann K; Broecker M
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5476-84. PubMed ID: 12466340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatase deficiency and estrogen resistance: from molecular genetics to clinic.
    Bulun SE
    Semin Reprod Med; 2000; 18(1):31-9. PubMed ID: 11305285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Of mice and men: the evolving phenotype of aromatase deficiency.
    Jones ME; Boon WC; Proietto J; Simpson ER
    Trends Endocrinol Metab; 2006 Mar; 17(2):55-64. PubMed ID: 16480891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oestrogen at the neonatal stage is critical for the reproductive ability of male mice as revealed by supplementation with 17beta-oestradiol to aromatase gene (Cyp19) knockout mice.
    Toda K; Okada T; Takeda K; Akira S; Saibara T; Shiraishi M; Onishi S; Shizuta Y
    J Endocrinol; 2001 Mar; 168(3):455-63. PubMed ID: 11241177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens.
    Morishima A; Grumbach MM; Simpson ER; Fisher C; Qin K
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3689-98. PubMed ID: 8530621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric endocrinology update: an overview. The essential roles of estrogens in pubertal growth, epiphyseal fusion and bone turnover: lessons from mutations in the genes for aromatase and the estrogen receptor.
    MacGillivray MH; Morishima A; Conte F; Grumbach M; Smith EP
    Horm Res; 1998; 49 Suppl 1():2-8. PubMed ID: 9554463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatase expression and role of estrogens in male gonad : a review.
    Carreau S; Lambard S; Delalande C; Denis-Galeraud I; Bilinska B; Bourguiba S
    Reprod Biol Endocrinol; 2003 Apr; 1():35. PubMed ID: 12747806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase deficiency in a Chinese adult man caused by novel compound heterozygous CYP19A1 mutations: effects of estrogen replacement therapy on the bone, lipid, liver and glucose metabolism.
    Chen Z; Wang O; Nie M; Elison K; Zhou D; Li M; Jiang Y; Xia W; Meng X; Chen S; Xing X
    Mol Cell Endocrinol; 2015 Jan; 399():32-42. PubMed ID: 25301327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.